NCT00946764View on ClinicalTrials.gov

To Demonstrate the Relative Bioavailability of Sandoz Inc. and Tyco Healthcare (Tofranil) 50 mg Imipramine Hydrochloride Tablets In Healthy Adults Volunteers Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

September 30, 2005

Study Completion Date

September 30, 2005

Conditions
Depression
Interventions
DRUG

Imipramine Hydrochloride 50 mg Tablets (Sandoz Inc.)

DRUG

Tofranil Imipramine Hydrochloride 50 mg Tablets (Tyco Healthcare)

Sponsors

Lead Sponsor

Sandoz
All Listed Sponsors
lead

Sandoz

INDUSTRY

NCT00946764 - To Demonstrate the Relative Bioavailability of Sandoz Inc. and Tyco Healthcare (Tofranil) 50 mg Imipramine Hydrochloride Tablets In Healthy Adults Volunteers Under Fasting Conditions | Biotech Hunter | Biotech Hunter